Literature DB >> 751089

Lung function in acromegaly.

B D Harrison, K A Millhouse, M Harrington, J D Nabarro.   

Abstract

Lung function has been assessed by spirometry, body plethysmography, flow volume loops and single breath transfer factor in thirty patients with acromegaly. Having excluded eight patients with kyphosis and/or clinical or radiological evidence of pulmonary venous hypertension we have found a significant correlation between duration of acromegaly and lung size as assessed by total lung capacity. Excluding the same eight patients we have found evidence of small airways narrowing in eight patients, seven of these eight had had acromegaly for nine years or longer, and the duration of acromegaly was significantly longer in the patients with small airways narrowing than in those without. In the absence of other recognized causes it is possible that small airways narrowing in acromegaly is caused either by the increased whole blood volume with pulmonary vascular engorgement, or by increase in size of the soft tissues of the small conducting airways. Six of the eight patients with kyphosis and/or pulmonary venous hypertension also had evidence of small airways narrowing. Thus fourteen of the thirty patients with acromegaly had small airways narrowing. Five men had evidence of extra thoracic airway narrowing and in four the duration of acromegaly was ten years or longer. We conclude that the increase in total lung capacity, the incidence of small airways narrowing and the incidence of upper airway narrowing are all related to the duration of acromegaly. It seems that once duration exceeds eight years patients are very likely to develop abnormalities of lung function either primarily from the effects of acromegaly on the airways and lung or secondarily from the associated cardiovascular and thoracic skeletal abnormalities. It seems probable that the small airways and upper airway narrowing contribute to the morbidity and mortality of this disease. This study provides further evidence that acromegaly should be treated early.

Entities:  

Mesh:

Year:  1978        PMID: 751089

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  12 in total

Review 1.  A history of acromegaly.

Authors:  R Sheaves
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

2.  Early lung function abnormalities in acromegaly.

Authors:  A Benfante; A Ciresi; M Bellia; F Cannizzaro; V Bellia; C Giordano; N Scichilone
Journal:  Lung       Date:  2015-03-11       Impact factor: 2.584

Review 3.  Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.

Authors:  Rosario Pivonello; Renata S Auriemma; Ludovica F S Grasso; Claudia Pivonello; Chiara Simeoli; Roberta Patalano; Mariano Galdiero; Annamaria Colao
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

4.  Determining airflow obstruction from tracheal sound analysis: simulated tests and evaluations in patients with acromegaly.

Authors:  Newton A Lima Junior; Nayara V Oliveira; Ana B W Tavares; Agnaldo J Lopes; Pedro L Melo
Journal:  Med Biol Eng Comput       Date:  2022-05-10       Impact factor: 2.602

5.  Growth hormone-dependent changes in the rat lung proteome during alveorization.

Authors:  J A Beyea; D M Olson; S Harvey
Journal:  Mol Cell Biochem       Date:  2008-11-05       Impact factor: 3.396

6.  CT pulmonary densitovolumetry in patients with acromegaly: a comparison between active disease and controlled disease.

Authors:  Gustavo B Camilo; Alysson R S Carvalho; Dequitier C Machado; Roberto Mogami; Pedro L Melo; Agnaldo J Lopes
Journal:  Br J Radiol       Date:  2015-08-06       Impact factor: 3.039

Review 7.  Cardiovascular complications in acromegaly: methods of assessment.

Authors:  G Vitale; R Pivonello; M Galderisi; A D'Errico; L Spinelli; G Lupoli; G Lombardi; A Colao
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

8.  Clinical manifestations and diagnosis of acromegaly.

Authors:  Gloria Lugo; Lara Pena; Fernando Cordido
Journal:  Int J Endocrinol       Date:  2012-02-01       Impact factor: 3.257

Review 9.  Recent developments in acromegaly: a review.

Authors:  A Jadresic
Journal:  J R Soc Med       Date:  1983-11       Impact factor: 18.000

10.  Prevalence of comorbidities and associated factors in acromegaly patients in the Turkish population

Authors:  Mustafa Can; Muhammet Kocabaş; İlker Çordan; Hatice Çalışkan Burgucu; Melia Karaköse; Mustafa Kulaksızoğlu; Feridun Karakurt
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.